Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists devise new way to generate canine stem cells
The iPSCs were generated without feeder cells, a process which had not been possible before.
The method reprograms the cells from urine samples.

Researchers have discovered a method to generate canine induced pluripotent stem cells (iPSCs) from urine samples.

The findings could bring companion animal medicine research a step closer to veterinary regenerative treatment.

The research, conducted by scientists at Osaka Metropolitan University, aimed to discover how iPSCs could be used in the study of veterinary regenerative medicine, as well as contributing to new discoveries in human regenerative medicine.

However, canine somatic cells have a much lower reprogramming efficiency than those of humans. This means that there are fewer types of canine cells which can be used to generate iPSCs.

The induction of iPSCs would often use feeder cells from a different species, although it is considered safer to minimise the use of xenogeneic components. Therefore, scientists were keen to find a method of reprogramming various canine cells in dogs without using feeder cells.

The research team were able to identify six reprogramming genes, which could increase canine iPSC generation by 120 times compared to conventional methods using fibroblasts.

Using these genes, the scientists were able to create iPSCs by reprogramming stem cells from canine urine samples. This was a non-invasive, painless and straight-forward method.

Not only were the scientists able to create the cells with reduced xenogeneic components, the iPSCs were also generated without feeder cells, a process which had not been possible before.

It is believed that this discovery could not only further studies of veterinary regenerative medicines, but also lead to new discoveries in human regenerative medicines.

Prof Shingo Hatoya, from the Graduate School of Veterinary Science at Osaka Metropolitan University, led the research team. They said: "As a veterinarian, I have examined and treated many animals,

"However, there are still many diseases that either cannot be cured or have not been fully understood. In the future, I am committed to continue my research on differentiating canine iPSCs into various types of cells and applying them to treat sick dogs, hopefully bringing joy to many animals and their owners."

The full study can be found in the journal Stem Cell Reports.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.